Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Bakersfield › NPI 1326717521
Clinic

Emergency Physicians Urgent Care INC

Emergency Physicians Urgent Care INC was paid $4.88M by Medicaid between Nov 2021 and Dec 2024, across 22 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 74% of everything it billed.

33Billing provider infoEMERGENCY PHYSICIANS URGENT CARE INC
BAKERSFIELD, CA 93306
33aNPI1326717521assigned 09/10/2021
28Total paid$4.88M
24GClaims89,615
24DCodes billed22
24AFirst – last monthNov 2021 – Dec 2024
Compared with peers

Next to other Urgent Care Clinic/Center providers in California

Rank by total paid#30 of 284
Median peer was paid$147K
This provider vs. median33×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official MASSIHI, ARTIN controls 15+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20211,547$81K
202229,922$1.49M
202332,257$1.54M
2024incomplete25,889$1.77M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 74% 34,609 34,065 $3.63M
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 22% 9,380 9,340 $1.08M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 2.5% 1,240 1,229 $120K
99215 Doctor's office visit, returning patient (complex)Prolong outpt/office vis <1% 299 297 $39K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity <1% 81 81 $8K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 16,084 15,873 $6K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 5,588 5,490 $1K
81003 <1% 6,914 6,847 $583.88
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 5,120 2,549 $322.83
81025 <1% 3,102 3,072 $272.88
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,495 2,442 $256.90
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 264 258 $34.99
10 more codes
71046 Radiologic examination, chest; 2 views <1% 388 $24.73
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 458 $20.69
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 1,521 $6.90
87807 <1% 217 $6.79
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,173 $5.76
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 136 $0.12
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) 0% 466 $0.00
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 0% 55 $0.00
73562 0% 12 $0.00
93000 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMASSIHI, ARTIN (OWNER)
Same official

Other billing entities under MASSIHI, ARTIN

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.